BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15941949)

  • 21. Past oral contraceptive and hormone therapy use and endogenous hormone concentrations in postmenopausal women.
    Chan MF; Dowsett M; Folkerd E; Wareham N; Luben R; Welch A; Bingham S; Khaw KT
    Menopause; 2008; 15(2):332-9. PubMed ID: 17667152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammographic breast density, hormones, and growth factors during continuous combined hormone therapy.
    Conner P; Svane G; Azavedo E; Söderqvist G; Carlström K; Gräser T; Walter F; von Schoultz B
    Fertil Steril; 2004 Jun; 81(6):1617-23. PubMed ID: 15193485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-like growth factor and mammographic density in postmenopausal Norwegian women.
    Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):57-62. PubMed ID: 17220332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physical activity and endogenous sex hormone levels in postmenopausal women: a cross-sectional study in the Prospect-EPIC Cohort.
    van Gils CH; Peeters PH; Schoenmakers MC; Nijmeijer RM; Onland-Moret NC; van der Schouw YT; Monninkhof EM
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):377-83. PubMed ID: 19190137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone therapy use and mammographic density in postmenopausal Norwegian women.
    Couto E; Qureshi SA; Hofvind S; Hilsen M; Aase H; Skaane P; Vatten L; Ursin G
    Breast Cancer Res Treat; 2012 Feb; 132(1):297-305. PubMed ID: 22052325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do sex hormones influence features of the metabolic syndrome in middle-aged women? A population-based study of Swedish women: the Women's Health in the Lund Area (WHILA) Study.
    Shakir YA; Samsioe G; Nyberg P; Lidfeldt J; Nerbrand C; Agardh CD
    Fertil Steril; 2007 Jul; 88(1):163-71. PubMed ID: 17383645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Body shape throughout life and correlations with IGFs and GH.
    Schernhammer ES; Tworoger SS; Eliassen AH; Missmer SA; Holly JM; Pollak MN; Hankinson SE
    Endocr Relat Cancer; 2007 Sep; 14(3):721-32. PubMed ID: 17914102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease.
    Joffe HV; Ridker PM; Manson JE; Cook NR; Buring JE; Rexrode KM
    Ann Epidemiol; 2006 Feb; 16(2):105-12. PubMed ID: 16216530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in profiles of circulating insulin-like growth factor components during hormone replacement therapy according to the responsiveness to therapy in postmenopausal women.
    Kim JG; Lee JY
    Am J Obstet Gynecol; 2001 May; 184(6):1139-44. PubMed ID: 11349179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-sectional association between markers of inflammation and serum sex steroid levels in the postmenopausal estrogen/progestin interventions trial.
    Crandall C; Palla S; Reboussin B; Hu P; Barrett-Connor E; Reuben D; Greendale G
    J Womens Health (Larchmt); 2006; 15(1):14-23. PubMed ID: 16417414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations among mammographic density, circulating sex hormones, and polymorphisms in sex hormone metabolism genes in postmenopausal women.
    Warren R; Skinner J; Sala E; Denton E; Dowsett M; Folkerd E; Healey CS; Dunning A; Doody D; Ponder B; Luben RN; Day NE; Easton D
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1502-8. PubMed ID: 16896040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations between reproductive and menstrual factors and postmenopausal androgen concentrations.
    Chubak J; Tworoger SS; Yasui Y; Ulrich CM; Stanczyk FZ; McTiernan A
    J Womens Health (Larchmt); 2005 Oct; 14(8):704-12. PubMed ID: 16232102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
    Tamimi RM; Byrne C; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Equol status modifies the association of soy intake and mammographic density in a sample of postmenopausal women.
    Fuhrman BJ; Teter BE; Barba M; Byrne C; Cavalleri A; Grant BJ; Horvath PJ; Morelli D; Venturelli E; Muti PC
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):33-42. PubMed ID: 18199709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.
    Undén AL; Elofsson S; Brismar K
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):94-102. PubMed ID: 15963068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method.
    Eilertsen AL; Karssemeijer N; Skaane P; Qvigstad E; Sandset PM
    BJOG; 2008 May; 115(6):773-9. PubMed ID: 18355366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of sex steroid replacement therapy on an expanded panel of IGF-related peptides.
    Renehan AG; Frystyk J; Howell A; O'dwyer ST; Shalet SM; Flyvbjerg A
    Growth Horm IGF Res; 2007 Jun; 17(3):210-9. PubMed ID: 17360217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.